blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1556389

EP1556389 - CEPHEM COMPOUNDS [Right-click to bookmark this link]
StatusThe patent has been limited
Status updated on  27.02.2015
Database last updated on 04.06.2024
Most recent event   Tooltip07.08.2015Correction of patent specificationpublished on 09.09.2015  [2015/37]
Applicant(s)For all designated states
Astellas Pharma Inc.
5-1, Nihonbashi-honcho 2-chome
Chuo-ku
Tokyo 103-8411 / JP
For all designated states
WAKUNAGA PHARMACEUTICAL CO., LTD.
5-36, Miyahara 4-chome, Yodogawa-ku Osaka-shi
Osaka 532-0003 / JP
[2015/14]
Former [2007/30]For all designated states
Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411 / JP
For all designated states
WAKUNAGA PHARMACEUTICAL CO., LTD.
5-36, Miyahara 4-chome, Yodogawa-ku Osaka-shi
Osaka 532-0003 / JP
Former [2005/30]For all designated states
Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome, Chuo-ku
Tokyo 103-8411 / JP
For all designated states
WAKUNAGA PHARMACEUTICAL CO., LTD.
5-36, Miyahara 4-chome, Yodogawa-ku
Osaka-shi, Osaka 532-0003 / JP
Inventor(s)01 / OHKI, Hidenori, @c/o Astellas Pharma Inc.
3-11 Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
02 / OKUDA, Shinya, @c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
03 / YAMANAKA, Toshio, @c/o Astellas Pharma Inc.
3-11, Nihonbashi-honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
04 / OHGAKI, Masaru, @c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
05 / TODA, Ayako, @c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
06 / KAWABATA, Kohji, @c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
07 / INOUE, Satoshi, @Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi
Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
08 / MISUMI, Keiji, @Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi
Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
09 / ITOH, Kenji, @Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi
Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
10 / SATOH, Kenji, @Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi
Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
 [2015/14]
Former [2007/26]01 / OHKI, Hidenori, c/o Astellas Pharma Inc.
3-11 Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
02 / OKUDA, Shinya, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
03 / YAMANAKA, Toshio, c/o Astellas Pharma Inc.
3-11, Nihonbashi-honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
04 / OHGAKI, Masaru, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
05 / TODA, Ayako, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
06 / KAWABATA, Kohji, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
07 / INOUE, Satoshi, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
08 / MISUMI, Keiji, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
09 / ITOH, Kenji, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
10 / SATOH, Kenji, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
Former [2005/30]01 / OHKI, Hidenori, c/o Astellas Pharma Inc.
3-11 Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
02 / OKUDA, Shinya, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
03 / YAMANAKA, Toshio, c/o Astellas Pharma Inc.
3-11, Nihonbashi-honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
04 / OHGAKI, Masaru, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
05 / TODA, Ayako, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
06 / KAWABATA, Kohji, c/o Astellas Pharma Inc.
3-11, Nihonbashi-Honcho 2-chome
Chuo-ku, Tokyo 103-8411 / JP
07 / INOUE, Satoshi, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
08 / MISUMI, Keiji, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
09 / ITOH, Kenji, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima73 9-1195 / JP
10 / SATOH, Kenji, Wakunaga Pharmaceutical Co., Ltd.
1624, Shimokotachi, Koda-cho
Takata-gun, Hiroshima 739-1195 / JP
Representative(s)Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte
Brucknerstraße 20
40593 Düsseldorf / DE
[N/P]
Former [2015/14]Gille Hrabal
Brucknerstrasse 20
40593 Düsseldorf / DE
Former [2005/30]Gille, Struck, Neidlein, Prop, Roos
Patentanwälte Brucknerstrasse 20
40593 Düsseldorf / DE
Application number, filing date03758919.927.10.2003
[2005/30]
WO2003JP13684
Priority number, dateAU2002095235530.10.2002         Original published format: AU 2002952355
AU2003090481304.09.2003         Original published format: AU 2003904813
[2005/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004039814
Date:13.05.2004
Language:EN
[2004/20]
Type: A1 Application with search report 
No.:EP1556389
Date:27.07.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 13.05.2004 takes the place of the publication of the European patent application.
[2005/30]
Type: B1 Patent specification 
No.:EP1556389
Date:25.07.2007
Language:EN
[2007/30]
Type: B3 Limited patent 
No.:EP1556389
Date:01.04.2015
Language:EN
[2015/14]
Type: B9 Corrected patent specification 
No.:EP1556389
Date:09.09.2015
[2015/37]
Search report(s)International search report - published on:EP13.05.2004
ClassificationIPC:C07D501/46, A61K31/546, A61P31/04
[2005/30]
CPC:
C07D501/00 (EP,US); C07D501/46 (KR); A61K31/546 (KR);
A61P31/04 (EP); Y02P20/55 (US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/30]
TitleGerman:CEPHEMVERBINDUNGEN[2005/30]
English:CEPHEM COMPOUNDS[2005/30]
French:COMPOSES CEPHEME[2005/30]
Entry into regional phase19.05.2005National basic fee paid 
19.05.2005Designation fee(s) paid 
19.05.2005Examination fee paid 
Examination procedure03.05.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
19.05.2005Examination requested  [2005/30]
30.10.2006Despatch of a communication from the examining division (Time limit: M02)
01.12.2006Reply to a communication from the examining division
17.01.2007Communication of intention to grant the patent
15.05.2007Fee for grant paid
15.05.2007Fee for publishing/printing paid
Opposition(s)28.04.2008No opposition filed within time limit [2008/27]
Limitations:21.07.2014Date of receipt of request for limitation
 admissible
11.02.2015Communication of intention to limit the patent
19.02.2015Fee for printing patent specification after limitation
31.10.2014Despatch of a communication from the examining division (Time limit: M02)
16.12.2014Reply to a communication from the examining division
Fees paidRenewal fee
25.10.2005Renewal fee patent year 03
19.10.2006Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY25.07.2007
CZ25.07.2007
EE25.07.2007
RO25.07.2007
SI25.07.2007
SK25.07.2007
BG25.10.2007
MC31.10.2007
[2009/34]
Former [2009/29]CZ25.07.2007
EE25.07.2007
RO25.07.2007
SI25.07.2007
SK25.07.2007
BG25.10.2007
MC31.10.2007
Former [2009/11]CZ25.07.2007
EE25.07.2007
RO25.07.2007
SK25.07.2007
BG25.10.2007
MC31.10.2007
Former [2008/28]CZ25.07.2007
RO25.07.2007
SK25.07.2007
BG25.10.2007
MC31.10.2007
Former [2008/25]CZ25.07.2007
SK25.07.2007
BG25.10.2007
MC31.10.2007
Former [2008/09]BG25.10.2007
Cited inInternational search[A]JPH04288086  ;
 [A]EP0047977  (CIBA GEIGY AG [CH]) [A] 1-17 * claim - *;
 [A]EP1134222  (SHIONOGI & CO [JP]) [A] 1-17 * claim - *;
 [PA]WO02090364  (FUJISAWA PHARMACEUTICAL CO [JP], et al) [PA] 1-17* claim - *;
 [A]  - DATABASE WPI, 1, Derwent World Patents Index, (1992), Database accession no. 1992-387716, XP002267713 & JPH04288086 A 19921013 (FUJISAWA PHARM CO LTD) [A] 1-17 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.